Peter Donato

Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology

Peter Donato, Matthew J. Roberts, Andrew Morton et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 110 citations · Full text

Medicine, Nuclear Medicine, Radiology +14

68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer

Matthew J. Roberts, Andrew Morton, Peter Donato et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 107 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?

Peter Donato, Andrew Morton, John Yaxley et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 97 citations · Full text

Medicine, Oncology, Urology +14

Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population‐based data

Andrew Morton, Michael Williams, Marlon Perera et al. · British Journal of Urology · 2020 · 50 citations · Full text

Medicine, Pharmacoeconomics, Urology +14

Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital

Peter Donato, Andrew Morton, John Yaxley et al. · World Journal of Urology · 2019 · 33 citations · Full text

Medicine, Oncology, Urology +14